Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,284 | 1,047 | 225 | 473 | 579 |
| Receivables | 110 | 179 | 113 | 475 | 122 |
| Inventories | 186 | 108 | 163 | 192 | 162 |
| TOTAL | $1,684 | $1,367 | $560 | $1,212 | $988 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 3 | 5 | 7 |
| Other Non-Current Assets | 1,684 | 1,737 | 1,789 | 1,842 | 1,894 |
| TOTAL | $1,685 | $1,738 | $1,792 | $1,847 | $1,901 |
| Total Assets | $3,369 | $3,105 | $2,352 | $3,059 | $2,889 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 835 | 908 | 1,030 | 1,033 | 1,073 |
| Accrued Expenses | 342 | 300 | 233 | 194 | 365 |
| TOTAL | $1,247 | $3,057 | $1,684 | $2,293 | $3,499 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 70 | 245 | 421 | 1,066 | 703 |
| Other Non-Current Liabilities | 7,386 | 0 | 0 | 0 | 3,109 |
| TOTAL | $7,803 | $434 | $452 | $N/A | $3,109 |
| Total Liabilities | $9,050 | $3,491 | $2,136 | $2,293 | $6,608 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,377 | 2,806 | 2,805 | 2,803 | 2,803 |
| Common Shares | 30 | 25 | 25 | 25 | 18 |
| Retained earnings | -114,165 | -103,348 | -102,642 | -101,988 | -106,794 |
| Other shareholders' equity | 72 | 73 | 72 | 73 | 74 |
| TOTAL | $-5,681 | $-386 | $216 | $766 | $-3,719 |
| Total Liabilities And Equity | $3,369 | $3,105 | $2,352 | $3,059 | $2,889 |